---
schema_version: "secwatch.filing_event.v1"
accession: "0001062822-24-000032"
form_type: "8-K"
ticker: "LXRX"
cik: "0001062822"
company_name: "LEXICON PHARMACEUTICALS, INC."
filed_at: "2024-07-01T23:59:59+00:00"
generated_at: "2026-05-31T23:54:47.119082+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Lexicon amends Oxford loan: interest-only period to May 2027, maturity to March 2029

## Summary
- Amortization date extended to May 1, 2027; maturity date extended to March 1, 2029.
- Final payment percentage increased from prior amount to 7.00% of outstanding principal.
- New financial covenant: minimum cash at 50% of outstanding Term Loans through June 30, 2026.
- Minimum trailing 6-month net product revenue tied to sNDA approval of sotagliflozin in CKD by March 31, 2025.
- Amendment fee paid; existing loan agreement continues in full force except as amended.

## SEC filing metadata
- accession: 0001062822-24-000032
- form_type: 8-K
- ticker: LXRX
- cik: 0001062822
- company_name: LEXICON PHARMACEUTICALS, INC.
- filed_at: 2024-07-01T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000032/0001062822-24-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1062822/000106282224000032/lxrx-20240628.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001062822-24-000032
- JSON: https://secwatch.observer/filing/0001062822-24-000032.json
- Plain text: https://secwatch.observer/filing/0001062822-24-000032.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.